Publications by authors named "I Leivo"

Introduction: Laryngeal chondrosarcoma (CS) is a rare indolent malignant tumor. High-grade (G3), dedifferentiated (DD), and myxoid (MY) CSs are considered more aggressive subtypes due to their metastatic potential and relatively poor outcomes. The aim of this systematic review is to evaluate treatment modalities and survival outcomes in patients affected by these rarer CS subtypes.

View Article and Find Full Text PDF

Background: There is a lack of prognosticators of overall survival (OS) for Oral Squamous Cell Carcinoma (OSCC).

Objectives: We examined collaborative machine learning (cML) in estimating the OS of OSCC patients. The prognostic significance of the clinicopathological parameters was examined.

View Article and Find Full Text PDF

Background: Tertiary lymphoid structures (TLSs) associate with prognosis of many malignancies. However, the clinical significance of TLSs is not well-elucidated in nasopharyngeal carcinoma (NPC) patients.

Material And Methods: In this whole population-based multicenter study, a total of 115 patients treated for NPC were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study reviews previous meta-analyses on histopathologic markers for predicting survival in patients with oral squamous cell carcinoma (OSCC), focusing on markers identified through routine HE staining.
  • An analysis of 16 published meta-analyses showed that depth of invasion and tumor thickness were the most significant indicators for lymph node metastasis.
  • The conclusion emphasizes the need to incorporate emerging prognostic markers like worst pattern of invasion and tumor-stroma ratio into regular pathology practices for better risk assessment of OSCC.
View Article and Find Full Text PDF

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and is a cause of significant mortality and morbidity. The epidemiology of this cancer varies worldwide due to either genetic differences in populations or differences in carcinogen exposure. The application of massive parallel sequencing-based techniques in HNSCC should provide a helpful understanding of the genetic alterations that eventually lead to HNSCC development and progression, and ideally, could be used for personalized therapy.

View Article and Find Full Text PDF